[Federal Register Volume 87, Number 232 (Monday, December 5, 2022)]
[Notices]
[Pages 74432-74434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26364]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Assay Validation of Biomarkers.
    Date: January 25, 2023.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609, Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Molecular Analysis Technologies (IMAT).
    Date: January 26, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W236, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shuli Xia, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609, Medical 
Center Drive, Room 7W236, Rockville, Maryland 20850, 240-276-5256, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Transition Career Development Award and Institutional 
Research Training Grants.
    Date: January 26, 2023.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH 9609, Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Radiation Oncology-Biology Integration Network (ROBIN) 
Centers Review.
    Date: January 27, 2023.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W640, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609, Medical Center Drive, Room 
7W640, Rockville, Maryland 20850, 240-276-7684, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review I.
    Date: January 31-February 1, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone 
Conference Call).

[[Page 74433]]

    Contact Person: Anita T. Tandle, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH 9609, Medical Center 
Drive, Room 7W248, Rockville, Maryland 20850, 240-276-5007, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review II.
    Date: February 2-3, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W244, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: John Paul Cairns, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH 9609, Medical Center 
Drive, Room 7W244, Rockville, Maryland 20850, 301-461-0303, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI-Pediatric Immunotherapy Network (PIN).
    Date: February 14, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609, Medical Center Drive, Room 
7W264, Rockville, Maryland 20850, 240-276-7286, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review III.
    Date: February 15-16, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W634, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Michael E. Lindquist, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH 9609, Medical Center 
Drive, Room 7W634, Rockville, Maryland 20850, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-C: NCI Program Project (P01).
    Date: February 15-16, 2023.
    Time: 9:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609, Medical Center Drive, Room 
7W248, Rockville, Maryland 20850, 240-672-6175, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Transition to Independence Study Section (I).
    Date: February 15-16, 2023.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609, Medical Center 
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Pancreatic Cancer Detection Consortium U01.
    Date: February 16, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W244, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: John Paul Cairns, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609, Medical Center 
Drive, Room 7W244, Rockville, Maryland 20850, 301-461-0303, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Trials Planning Program.
    Date: February 17, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project (P01) Review SEP-B.
    Date: February 21-22, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Rockville, Maryland 20850, 240-276-6611, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) Review IV.
    Date: February 23-24, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W522, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NCI, 9609 Medical Center 
Drive, Room 7W522, Rockville, Maryland 20850, 240-276-5413, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Career Development Study Section (J).
    Date: February 27-28, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W624, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W624, Rockville, Maryland 20850, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Review of Research Projects (U01) in Physical Sciences-
Oncology.
    Date: March 1, 2023.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W640, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Rockville, Maryland 20850, 240-276-7684, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project (P01) SEP-A.
    Date: March 2-3, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W120, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Majed M. Hamawy, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W120, Rockville, Maryland 20850, 240-276-6457, 
[email protected].


[[Page 74434]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Adoptive Cellular Therapy Network (Can-ACT).
    Date: March 2, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W112, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Shari Williams Campbell, D.P.M, MSHS, Scientific 
Review Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W112, Rockville, Maryland 20850, 240-276-7381, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
    Date: March 3, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Rockville, Maryland 20850, 240-276-7286, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Global Implementation Science for Equitable Cancer Control.
    Date: March 8-9, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 29, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26364 Filed 12-2-22; 8:45 am]
BILLING CODE 4140-01-P